Bridget Ford
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Advanced Glycation End Products research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Papers in
-
- Epigenetics and DNA Methylation 3
- Mitochondrial Function and Pathology 2
- RNA modifications and cancer 2
-
- Chronic Kidney Disease and Diabetes 2
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Hanna E. Abboud (3 shared papers)Assaad A. Eid (3 shared papers)Jeffrey L. Barnes (3 shared papers)Yves Gorin (3 shared papers)Karen Block (2 shared papers)Douglas L. Arnold (2 shared papers)George Karpati (2 shared papers)Paul M. Matthews (2 shared papers)
- Journals
- Neurology (2 papers)Toxicology and Applied Pharmacology (1 paper)Gene (1 paper)Diabetes (1 paper)Disease Markers (1 paper)
- Partner nations
- United StatesIndiaLebanon
In The Last Decade
Bridget Ford
14 papers receiving 729 citations
Peers
Comparison fields: 5 of 87
- Clinical Biochemistry 156
- Nephrology 117
- Biochemistry 55
- Molecular Biology 392
- Geriatrics and Gerontology 16
Countries citing papers authored by Bridget Ford
This map shows the geographic impact of Bridget Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Ford more than expected).
Fields of papers citing papers by Bridget Ford
This network shows the impact of papers produced by Bridget Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Ford. The network helps show where Bridget Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Bridget Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 225 | |
| 2 | 1995 | 128 | |
| 3 | 2013 | 121 | |
| 4 | 1993 | 92 | |
| 5 | 2013 | 42 | |
| 6 | 2022 | 41 | |
| 7 | 2019 | 25 | |
| 8 | 2020 | 20 | |
| 9 | 2015 | 14 | |
| 10 | 2021 | 10 | |
| 11 | 2017 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 2022 | 4 | |
| 14 | 2019 | 1 | |
| 15 | 2016 | 0 |
About Bridget Ford
Bridget Ford is a scholar working on Molecular Biology, Nephrology, Clinical Biochemistry, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 742 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Metabolism and Genetic Disorders (2 papers), Mitochondrial Function and Pathology (2 papers), Renal Diseases and Glomerulopathies (2 papers), Advanced MRI Techniques and Applications (2 papers), RNA modifications and cancer (2 papers) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Clinical Biochemistry (156 citations), Nephrology (117 citations), Biochemistry (55 citations), Molecular Biology (392 citations) and Geriatrics and Gerontology (16 citations). Bridget Ford has collaborated with scholars based in United States, India and Lebanon. Frequent co-authors include Hanna E. Abboud, Assaad A. Eid, Jeffrey L. Barnes, Yves Gorin, Karen Block, Douglas L. Arnold, George Karpati, Paul M. Matthews, Goutam Ghosh-Choudhury and Balakuntalam S. Kasinath. Their work appears in journals such as Neurology, Toxicology and Applied Pharmacology, Gene, Diabetes and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.